Fulgent GeneticsFLGT +5.17%59 OCF Margin % is 9.98% as of Mar. 2026, which is 24% below its 10-year median of 13.15. GuruFocus rates FLGT with a GF Score™ of 59/100 and a GF Value™ of $23.98 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Fulgent Genetics ranks worse than 75% on this metric.
The historical rank and industry rank for Fulgent Genetics's OCF Margin % or its related term are showing as below:
FLGT'
s OCF Margin % Range Over the Past 10 Years
Min: -31.5 Med: 13.15 Max: 54.26
Current: -28.13
During the past 12 years, the highest OCF Margin % of Fulgent Genetics was 54.26%. The lowest was -31.50%. And the median was 13.15%.
FLGT's OCF Margin % is ranked worse than 75% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755
vs FLGT: -28.13
Fulgent Genetics OCF Margin % Related Terms
Fulgent Genetics OCF Margin % Historical Data
* Premium members only.
The historical data trend for Fulgent Genetics's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Fulgent Genetics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fulgent Genetics OCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Fulgent Genetics's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Fulgent Genetics's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fulgent Genetics (FLGT) has a OCF Margin % of 9.98% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Fulgent Genetics and its competitors. This is 24% below median its historical median of 13.15. According to the industry distribution chart, Fulgent Genetics ranks #153 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 75%.
Is Fulgent Genetics' OCF Margin % too high?
Fulgent Genetics' current OCF Margin % of 9.98% is 24% below median its 10-year median of 13.15. The Medical Diagnostics & Research industry median OCF Margin % is 4.76. Fulgent Genetics' value of 9.98% is 109.9% above this industry median. Based on the distribution chart, Fulgent Genetics ranks #153 out of 204 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Fulgent Genetics has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fulgent Genetics' OCF Margin % compare to CSTL and MYGN?
According to the Medical Diagnostics & Research industry distribution chart, Fulgent Genetics ranks #153 out of 204 companies for OCF Margin %. This places Fulgent Genetics in the lower half of its industry. The industry median OCF Margin % is 4.76. Fulgent Genetics' value of 9.98% is 109.9% above this benchmark. While the company's 10-year median is 13.15 vs. the industry median of 4.76, Fulgent Genetics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fulgent Genetics's current OCF Margin % of 9.98% is 109.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Fulgent Genetics and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fulgent Genetics's current OCF Margin % is 9.98%, which is 24% below median its own 10-year median of 13.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fulgent Genetics stock overvalued right now?
Based on GuruFocus' analysis, Fulgent Genetics (FLGT) is currently considered Modestly Undervalued. The stock's GF Value™ is $23.98, compared to a current price of $19.13 — trading 20.2% below its estimated fair value. The current OCF Margin % is 9.98%, which is 24% below median its 10-year median of 13.15 and 109.9% above the Medical Diagnostics & Research industry median of 4.76. Fulgent Genetics' overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Fulgent Genetics (FLGT), the current OCF Margin % is 9.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fulgent Genetics (FLGT) Overvalued in 2026?
Based on GuruFocus' analysis, Fulgent Genetics stock appears to be undervalued.
The current stock price of $19.13 is trading 20.2% below its estimated GF Value™ of $23.98.
GuruFocus considers Fulgent Genetics to be Modestly Undervalued.
Key valuation signals for FLGT:
OCF Margin %: 9.98% (24% below median its 10-year median of 13.15)
GF Value™: $23.98 vs. price of $19.13 (20.2% below fair value)
Industry Position: 109.9% above the Medical Diagnostics & Research median (#153 of 204)
No single metric tells the full story. See the FLGT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
59GF Score
Get the complete analysis for FLGT
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FLGT has been successfully added to your 
